Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $2.08 billion. The enterprise value is $1.75 billion.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 132.97 million shares outstanding. The number of shares has decreased by -5.13% in one year.
| Current Share Class | 132.97M |
| Shares Outstanding | 132.97M |
| Shares Change (YoY) | -5.13% |
| Shares Change (QoQ) | +1.58% |
| Owned by Insiders (%) | 0.93% |
| Owned by Institutions (%) | 59.42% |
| Float | 130.61M |
Valuation Ratios
The trailing PE ratio is 7.54 and the forward PE ratio is 19.19.
| PE Ratio | 7.54 |
| Forward PE | 19.19 |
| PS Ratio | 7.33 |
| Forward PS | 6.28 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | 15.33 |
| P/OCF Ratio | 15.30 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.91, with an EV/FCF ratio of 12.94.
| EV / Earnings | 6.10 |
| EV / Sales | 6.19 |
| EV / EBITDA | 12.91 |
| EV / EBIT | 15.07 |
| EV / FCF | 12.94 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.25 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 0.55 |
| Interest Coverage | 26.85 |
Financial Efficiency
Return on equity (ROE) is 59.91% and return on invested capital (ROIC) is 66.31%.
| Return on Equity (ROE) | 59.91% |
| Return on Assets (ROA) | 11.16% |
| Return on Invested Capital (ROIC) | 66.31% |
| Return on Capital Employed (ROCE) | 17.67% |
| Weighted Average Cost of Capital (WACC) | 12.34% |
| Revenue Per Employee | $2.21M |
| Profits Per Employee | $2.24M |
| Employee Count | 128 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | -173.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.91% in the last 52 weeks. The beta is 1.52, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +93.91% |
| 50-Day Moving Average | 14.51 |
| 200-Day Moving Average | 13.01 |
| Relative Strength Index (RSI) | 62.81 |
| Average Volume (20 Days) | 1,147,482 |
Short Selling Information
The latest short interest is 10.16 million, so 7.64% of the outstanding shares have been sold short.
| Short Interest | 10.16M |
| Short Previous Month | 9.75M |
| Short % of Shares Out | 7.64% |
| Short % of Float | 7.78% |
| Short Ratio (days to cover) | 9.72 |
Income Statement
In the last 12 months, AUPH had revenue of $283.06 million and earned $287.20 million in profits. Earnings per share was $2.07.
| Revenue | 283.06M |
| Gross Profit | 217.89M |
| Operating Income | 116.26M |
| Pretax Income | 114.16M |
| Net Income | 287.20M |
| EBITDA | 135.71M |
| EBIT | 116.26M |
| Earnings Per Share (EPS) | $2.07 |
Full Income StatementBalance Sheet
The company has $397.94 million in cash and $74.81 million in debt, with a net cash position of $323.13 million or $2.43 per share.
| Cash & Cash Equivalents | 397.94M |
| Total Debt | 74.81M |
| Net Cash | 323.13M |
| Net Cash Per Share | $2.43 |
| Equity (Book Value) | 581.33M |
| Book Value Per Share | 4.39 |
| Working Capital | 398.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $135.66 million and capital expenditures -$252,000, giving a free cash flow of $135.41 million.
| Operating Cash Flow | 135.66M |
| Capital Expenditures | -252,000 |
| Depreciation & Amortization | 19.45M |
| Net Borrowing | -13.14M |
| Free Cash Flow | 135.41M |
| FCF Per Share | $1.02 |
Full Cash Flow StatementMargins
Gross margin is 76.98%, with operating and profit margins of 41.07% and 101.47%.
| Gross Margin | 76.98% |
| Operating Margin | 41.07% |
| Pretax Margin | 40.33% |
| Profit Margin | 101.47% |
| EBITDA Margin | 47.94% |
| EBIT Margin | 41.07% |
| FCF Margin | 47.84% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.13% |
| Shareholder Yield | 5.13% |
| Earnings Yield | 13.84% |
| FCF Yield | 6.52% |
Analyst Forecast
The average price target for AUPH is $17.25, which is 10.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 10.51% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 13.26% |
| EPS Growth Forecast (5Y) | -9.46% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 5.22 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.22 |
| Piotroski F-Score | 5 |
